Growth Metrics

Mimedx Group (MDXG) Debt to Equity: 2011-2025

Historic Debt to Equity for Mimedx Group (MDXG) over the last 10 years, with Sep 2025 value amounting to $0.08.

  • Mimedx Group's Debt to Equity fell 33.91% to $0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.08, marking a year-over-year decrease of 33.91%. This contributed to the annual value of $0.10 for FY2024, which is 71.66% down from last year.
  • Mimedx Group's Debt to Equity amounted to $0.08 in Q3 2025, which was down 10.55% from $0.09 recorded in Q2 2025.
  • Mimedx Group's 5-year Debt to Equity high stood at $586.91 for Q4 2021, and its period low was -$8.27 during Q3 2021.
  • Its 3-year average for Debt to Equity is $2.85, with a median of $0.10 in 2024.
  • As far as peak fluctuations go, Mimedx Group's Debt to Equity slumped by 375.47% in 2021, and later soared by 1,582.54% in 2023.
  • Over the past 5 years, Mimedx Group's Debt to Equity (Quarterly) stood at $586.91 in 2021, then slumped by 100.46% to -$2.70 in 2022, then skyrocketed by 112.73% to $0.34 in 2023, then tumbled by 71.66% to $0.10 in 2024, then slumped by 33.91% to $0.08 in 2025.
  • Its last three reported values are $0.08 in Q3 2025, $0.09 for Q2 2025, and $0.09 during Q1 2025.